BCAT: NAV May Continue To Erode Due To Generous Distribution (Rating Downgrade)

2025-03-11 18:36:32 ET

Summary

• BlackRock Capital Allocation Term Trust offers a 22.7% dividend yield, making it attractive for income-focused investors despite a 4.3% price decline in the past year.
• BCAT's blended portfolio of equities and fixed income assets, including a strategic option strategy, limits capital appreciation but ensures steady income through premiums.
• The fund trades at a 4.6% discount to NAV, with a diverse sector exposure.
• Despite its high yield, BCAT's sensitivity to interest rates and reliance on market momentum pose risks.
• The fund is currently paying out more in distributions than it actually earns from underlying assets.

Overview

BlackRock Capital Allocation Term Trust ( BCAT ) operates as a closed end fund that aims to provide an attractive total return through its blended portfolio of equities and fixed income assets. I previously covered BCAT and issued a buy rating due to the attractive valuation and outlook regarding interest rate cuts. Now that we've crossed into 2025 and some new reporting documents were released, I wanted to revisit this fund to reassess and provide some updated insights. Additionally, the outlook on interest rate cuts has shifted to a less favorable stance, which will likely cause an earnings shift from the income assets held within BCAT....

Read the full article on Seeking Alpha

For further details see: